Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

CorMedix (CRMD) Return on Capital Employed: 2012-2025

Historic Return on Capital Employed for CorMedix (CRMD) over the last 9 years, with Sep 2025 value amounting to 0.28%.

  • CorMedix's Return on Capital Employed rose 121.00% to 0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28%, marking a year-over-year increase of 121.00%. This contributed to the annual value of -0.52% for FY2022, which is 3.00% up from last year.
  • According to the latest figures from Q3 2025, CorMedix's Return on Capital Employed is 0.28%, which was down 3.01% from 0.29% recorded in Q2 2025.
  • Over the past 5 years, CorMedix's Return on Capital Employed peaked at 0.29% during Q2 2025, and registered a low of -1.05% during Q2 2024.
  • For the 3-year period, CorMedix's Return on Capital Employed averaged around -0.43%, with its median value being -0.62% (2023).
  • Its Return on Capital Employed has fluctuated over the past 5 years, first decreased by 30bps in 2024, then soared by 134bps in 2025.
  • CorMedix's Return on Capital Employed (Quarterly) stood at -0.44% in 2021, then fell by 11bps to -0.55% in 2022, then dropped by 12bps to -0.63% in 2023, then dropped by 30bps to -0.35% in 2024, then spiked by 121bps to 0.28% in 2025.
  • Its last three reported values are 0.28% in Q3 2025, 0.29% for Q2 2025, and 0.14% during Q1 2025.